Development of Layer-by-Layer Magnetic Nanoparticles for Application to Radiotherapy of Pancreatic Cancer
Molecules · 2025
DOI: 10.3390/molecules30061382 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Nobuyoshi Fukumitsu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Kobe Proton Center, Kobe 650-0047, Japan. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Magnetite Nanoparticles, Deoxycytidine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Tsukuba Innovation Arena (TIA) Collaborative Program Exploration and Promotion Project Kakehashi, JSPS KAKENHI.
Abstract (Originalsprache)
Pancreatic cancer is among the deadliest malignancies, with few treatment options for locally advanced, unresectable cases. Conventional therapies, such as chemoradiotherapy and hyperthermia, show promise but face challenges in improving outcomes. This study introduces a novel drug delivery system using gemcitabine (GEM)-loaded layer-by-layer magnetic nanoparticles (LBL MNPs) combined with alternating magnetic field (AMF) application and X-ray irradiation to enhance therapeutic efficacy. LBL MNPs were synthesized using optimized layering techniques to achieve superior drug loading and controlled release. Human pancreatic cancer cells (PANC-1) were treated with LBL MNPs alone, with AMF-induced hyperthermia, and in combination with X-rays. The results demonstrate that the 7-layer LBL MNPs exhibited optimal cytotoxicity, significantly reducing cell viability at concentrations of 30 µg/mL and higher. Combining 7-layer LBL MNPs with AMF increased cell death in a time- and concentration-dependent manner, achieving up to 98% inhibition of cell proliferation. The addition of X-rays to the regimen demonstrated a strong synergistic effect, resulting in a 13-fold increase in cell death compared to controls. These findings highlight the potential of this integrated approach to improve outcomes in patients with pancreatic cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Kobe Proton Center, Kobe 650-0047, Japan.
- Department of Radiation Oncology, Clinical Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan.
- Proton Medical Research Center, University of Tsukuba Hospital, Tsukuba 305-8576, Japan.
- Smart Polymers Group, Research Center for Macromolecules and Biomaterials, National Institute for Materials Science, Tsukuba 305-0044, Japan.
ORCID-Profile: Nobuyoshi Fukumitsu, Yoshitaka Matsumoto, Lili Chen, Nanami Fujisawa, Emiho Oe, Takashi Saito, Mitsuhiro Ebara
Förderung
- Japan Society for the Promotion of Science
- Tsukuba Innovation Arena (TIA) Collaborative Program Exploration and Promotion Project Kakehashi
- JSPS KAKENHI
Zitieren
APA
Fukumitsu, N., Matsumoto, Y., Chen, L., Sugawara, Y., Fujisawa, N., Niiyama, E., Ouchi, S., Oe, E., Saito, T., & Ebara, M. (2025). Development of Layer-by-Layer Magnetic Nanoparticles for Application to Radiotherapy of Pancreatic Cancer. Molecules. https://doi.org/10.3390/molecules30061382
Vancouver
Fukumitsu N, Matsumoto Y, Chen L, Sugawara Y, Fujisawa N, Niiyama E, et al. Development of Layer-by-Layer Magnetic Nanoparticles for Application to Radiotherapy of Pancreatic Cancer. Molecules. 2025. doi:10.3390/molecules30061382
BibTeX
@article{Fukumitsu2025,
author = {Fukumitsu, Nobuyoshi and Matsumoto, Yoshitaka and Chen, Lili and Sugawara, Yu and Fujisawa, Nanami and Niiyama, Eri and Ouchi, Sosuke and Oe, Emiho and Saito, Takashi and Ebara, Mitsuhiro},
title = {Development of Layer-by-Layer Magnetic Nanoparticles for Application to Radiotherapy of Pancreatic Cancer},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30061382}
}
EUVIMED